These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2572499)

  • 21. Cytotoxic T lymphocytes, interleukin-2 and trophoblast involvement.
    Toder V; Blank M; Nebel L
    Contrib Gynecol Obstet; 1985; 14():23-35. PubMed ID: 2415297
    [No Abstract]   [Full Text] [Related]  

  • 22. A requirement for physical linkage between determinants recognized by helper molecules and cytotoxic T cell precursors in the induction of cytotoxic T cell responses.
    Krowka JF; Singh B; Fotedar A; Mosmann T; Giedlin MA; Pilarski LM
    J Immunol; 1986 May; 136(10):3561-6. PubMed ID: 2422257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo.
    Lee RS; Grusby MJ; Glimcher LH; Winn HJ; Auchincloss H
    J Exp Med; 1994 Mar; 179(3):865-72. PubMed ID: 8113680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen processing for presentation to CD4+ T cells.
    Long EO
    New Biol; 1992 Apr; 4(4):274-82. PubMed ID: 1535789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of class II major histocompatibility complex molecules on antigen presenting cells after interaction with helper T cells.
    Vidović D; Falcioni F; Bolin DR; Nagy ZA
    Eur J Immunol; 1995 May; 25(5):1326-31. PubMed ID: 7774635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens.
    Livingstone AM; Kuhn M
    Eur J Immunol; 1999 Sep; 29(9):2826-34. PubMed ID: 10508257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.
    Ottenhoff TH; Mutis T
    J Exp Med; 1990 Jun; 171(6):2011-24. PubMed ID: 1972178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human antimurine xenogeneic cytotoxic response. I. Dependence on responder antigen-presenting cells.
    Lucas PJ; Shearer GM; Neudorf S; Gress RE
    J Immunol; 1990 Jun; 144(12):4548-54. PubMed ID: 1972159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Processing of a minimal antigenic peptide alters its interaction with MHC molecules.
    Fox BS; Carbone FR; Germain RN; Paterson Y; Schwartz RH
    Nature; 1988 Feb; 331(6156):538-40. PubMed ID: 2448649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conventional antigen and superantigen may be coupled to distinct and cooperative T-cell activation pathways.
    Liu H; Lampe MA; Iregui MV; Cantor H
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8705-9. PubMed ID: 1681539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costimulator deficient antigen presentation by an endothelial cell line induces a nonproliferative T cell activation response without anergy.
    St Louis JD; Lederer JA; Lichtman AH
    J Exp Med; 1993 Nov; 178(5):1597-605. PubMed ID: 7693852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
    Mangino G; Grazia Capri M; Barnaba V; Alberti S
    Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of V beta 8.2+ CD4+ T cells induced by a superantigen: roles of antigen-presenting cells and cytokines.
    McKnight AJ; Shea CM; Wiens GR; Rimm IJ; Abbas AK
    Immunology; 1994 Apr; 81(4):513-20. PubMed ID: 7913692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of tumor-specific T cell response by cognating tumor cells with foreign antigen-primed Th cells.
    Cheng TY; Wu JT; Lin RH
    Int Immunol; 1998 Oct; 10(10):1397-406. PubMed ID: 9796906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
    Klarnet JP; Kern DE; Okuno K; Holt C; Lilly F; Greenberg PD
    J Exp Med; 1989 Feb; 169(2):457-67. PubMed ID: 2562982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity.
    Cortesini R; LeMaoult J; Ciubotariu R; Cortesini NS
    Immunol Rev; 2001 Aug; 182():201-6. PubMed ID: 11722635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photoaffinity labeling demonstrates binding between Ia molecules and nominal antigen on antigen-presenting cells.
    Phillips ML; Yip CC; Shevach EM; Delovitch TL
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5634-8. PubMed ID: 2942939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and molecular aspects of antigen processing and the function of class II MHC molecules.
    Harding CV
    Am J Respir Cell Mol Biol; 1993 May; 8(5):461-7. PubMed ID: 8481229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antigen processing and antigen presentation by accessory cells of the immune system].
    Langner J
    Allerg Immunol (Leipz); 1985; 31(3):131-56. PubMed ID: 2416210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.